Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IDNA?
Track your performance easily
IDNA Technical Analysis
Summary of all the Indicators
Summary
Sell
7Bullish
2Neutral
13Bearish
Oscillators
Buy
6Bullish
2Neutral
2Bearish
Moving Averages
Strong Sell
1Bullish
0Neutral
11Bearish
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) Moving Averages Convergence Divergence (MACD) indicator is -0.42, suggesting iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund is a Buy.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 20-Day exponential moving average is 22.61, making it a Sell.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 50-Day exponential moving average is 23.20, making it a Sell.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) Pivot Points
Classic
21.54
21.67
21.78
21.91
22.02
22.15
22.26
Fibonacci
21.67
21.76
21.82
21.91
22.00
22.05
22.15
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) Moving Averages
MA5
21.85Buy
22.02Sell
MA10
22.48Sell
22.27Sell
MA20
22.58Sell
22.61Sell
MA50
23.44Sell
23.20Sell
MA100
23.91Sell
23.55Sell
MA200
23.73Sell
23.55Sell
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 10-Day exponential moving average is 22.27, making it a Sell.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 100-Day exponential moving average is 23.55, making it a Sell.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 50-day simple moving average is 23.44, creating a Sell signal.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 100-day simple moving average is 23.91, creating a Sell signal.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) 200-day simple moving average is 23.73, creating a Sell signal.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) Technical Analysis
RSI (14)
37.14
Neutral
STOCH (9,6)
16.53
Buy
STOCHRSI (14)
16.53
Buy
MACD (12,26)
-0.42
Buy
ADX (14)
19.29
Buy
Williams %R
-83.47
Buy
CCI (14)
-103.21
Buy
ATR (14)
0.47
-
Ultimate Oscillator
30.49
Neutral
ROC
-4.57
Sell
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) Relative Strength Index (RSI) is 37.14, creating a Neutral signal.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) Trend Strength Indicator (ADX) is 19.29, creating a Buy signal.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) Commodity Channel Index (CCI) is -103.21, creating a Buy signal.
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund’s (IDNA) Price Rate of Change (ROC) is -4.57, creating a Sell signal.
FAQ
Is IDNA a Buy, Hold, or Sell?
Based on IDNA’s technical indicators, IDNA is a Sell.
What is IDNA’s RSI (14)?
IDNA’s RSI (14) is 37.14, which suggests IDNA is a Neutral.
What is IDNA’s MACD?
IDNA’s MACD is -0.42, which suggests IDNA is a Buy.
What is IDNA’s 5-day moving average?
IDNA’s 5-day moving average is 21.85, which suggests IDNA is a Buy.
What is IDNA’s 20-day moving average?
IDNA 20-day moving average is 22.58, which suggests IDNA is a Sell.
What is IDNA’s 50-day moving average?
IDNA’s 50-day moving average is 23.44, which suggests IDNA is a Sell.
What is IDNA’s 200-day moving average?
IDNA’s 200-day moving average is 23.73, which suggests IDNA is a Sell.
What is IDNA’s Williams % R (14)?
IDNA’s Williams % R (14) is -83.47, which suggests IDNA is a Buy.
What is IDNA’s CCI (14)?
IDNA’s CCI (14) is -103.21, which suggests IDNA is a Buy.